All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
How did newer prognostic models change treatment algorithms in primary and secondary MF?
During the Society of Hematologic Oncology (SOHO) 2021 Annual Meeting, the MPN Hub spoke with Laura Michaelis, Medical College of Wisconsin, Milkwaukee, US. We...
Special populations in MPN: pediatric, adolescent, and young adults with MPN
Triple negative mutations i.e., the absence of driver mutations in JAK2, MPN and CALR are reported in many young patients with myeloproliferative neoplasms (MPN).
"In the MPN Hub, we have gathered the most recent and most relevant information about MPN pathophysiology, clinical advances, and therapy. You are sure to find a response to your burning questions about MPN here!"